Influenza Vaccine in Heart Failure: Cumulative Number of Vaccinations, Frequency, Timing, and Survival: A Danish Nationwide Cohort Study

Circulation

Volumn 139, Issue 5, 2019, Pages 575-586

  Modin, Daniel ^a   Jørgensen, Mads Emil ^a   Gislason, Gunnar ^a   Jensen, Jan Skov ^a   Køber, Lars ^a,b   Claggett, Brian ^c   Hegde, Sheila M ^c   Solomon, Scott D ^c   Torp Pedersen, Christian ^a   Biering Sørensen, Tor ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

communicable diseases; heart failure; influenza, human; prognosis; survival; therapeutics; vaccination

Indexed keywords

INFLUENZA VACCINE; SPIRONOLACTONE;

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DENMARK; FOLLOW UP; GENERAL PRACTITIONER; HEART ARRHYTHMIA; HEART FAILURE; HOUSEHOLD INCOME; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; VACCINATION; EPIDEMIOLOGY; FEMALE; HEALTH STATUS; IMMUNIZATION; INFLUENZA; MIDDLE AGED; MORTALITY; PROTECTION; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; VIROLOGY;

AGED; AGED, 80 AND OVER; DENMARK; FEMALE; HEALTH STATUS; HEART FAILURE; HUMANS; IMMUNIZATION SCHEDULE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROTECTIVE FACTORS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85060567006     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.118.036788     Document Type: Article

References (33)

1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation 2017 135 e146 e603. doi: 10.1161/CIR.0000000000000485
2. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG, American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association. Circ Heart Fail 2013 6 606 619. doi: 10.1161/HHF.0b013e318291329a
3. Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, Naghavi M, Mensah GA, Murray CJ, Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 2015 372 1333 1341. doi: 10.1056/NEJMoa1406656
4. Sandoval C, Walter SD, Krueger P, Smieja M, Smith A, Yusuf S, Loeb MB, Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure. Epidemiol Infect 2007 135 574 582. doi: 10.1017/S095026880600714X
5. Uchmanowicz I, Łoboz-Rudnicka M, Szelag P, Jankowska-Polańska B, Łoboz-Grudzień K, Frailty in heart failure. Curr Heart Fail Rep 2014 11 266 273. doi: 10.1007/s11897-014-0198-4
6. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP, Association between influenza vaccination and cardiovascular outcomes in high-risk patients: A meta-analysis. JAMA 2013 310 1711 1720. doi: 10.1001/jama.2013.279206
7. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, Van Der Meer P, 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC): developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016 18 891 975. doi: 10.1002/ejhf.592
8. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 128 1810 1852
9. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM, American Heart Association; American College of Cardiology; American Association of Cardiovascular and Pulmonary Rehabilitation; American Association of Critical Care Nurses; American Association of Heart Failure Nurses; American Diabetes Association; Association of Black Cardiologists, Inc; Heart Failure Society of America; Preventive Cardiovascular Nurses Association; American Academy of Nurse Practitioners; Centers for Disease Control and Prevention and the Advisory Committee on Immunization Influenza vaccination as secondary prevention for cardiovascular disease: A science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol 2006 48 1498 1502. doi: 10.1016/j.jacc.2006.09.004
10. Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, Swedberg K, Desai AS, Lefkowitz M, Shi V, McMurray JJV, Solomon SD, PARADIGM-HF Investigators Influenza vaccination in patients with chronic heart failure: The PARADIGM-HF trial. JACC Heart Fail 2016 4 152 158. doi: 10.1016/j.jchf.2015.10.012
11. Mohseni H, Kiran A, Khorshidi R, Rahimi K, Influenza vaccination and risk of hospitalization in patients with heart failure: A self-controlled case series study. Eur Heart J 2017 38 326 333. doi: 10.1093/eurheartj/ehw411
12. Pedersen CB, The Danish Civil Registration System. Scand J Public Health 2011 39 suppl 22 25. doi: 10.1177/1403494810387965
13. Thygesen LC, Daasnes C, Thaulow I, Brønnum-Hansen H, Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 2011 39 suppl 12 16. doi: 10.1177/1403494811399956
14. Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT, The Danish National Patient Registry: A review of content, data quality, and research potential. Clin Epidemiol 2015 7 449 490. doi: 10.2147/CLEP.S91125
15. Kümler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Køber L, Torp-Pedersen C, Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 2008 10 658 660. doi: 10.1016/j.ejheart.2008.05.006
16. Sundbøll J, Adelborg K, Munch T, Frøslev T, Sørensen HT, Bøtker HE, Schmidt M, Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: A validation study. BMJ Open 2016 6 e012832. doi: 10.1136/bmjopen-2016-012832
17. Giobbie-Hurder A, Gelber RD, Regan MM, Challenges of guarantee-time bias. J Clin Oncol 2013 31 2963 2969. doi: 10.1200/JCO.2013.49.5283
18. Suissa S, Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008 167 492 499. doi: 10.1093/aje/kwm324
19. Cho IS, Chae YR, Kim JH, Yoo HR, Jang SY, Kim GR, Nam CM, Statistical methods for elimination of guarantee-time bias in cohort studies: A simulation study. BMC Med Res Methodol 2017 17 126. doi: 10.1186/s12874-017-0405-6
20. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B, Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J 2004 25 25 31
21. Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, Ksiezycka E, Przyluski J, Piotrowski W, Maczynska R, Ruzyllo W, Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008 29 1350 1358. doi: 10.1093/eurheartj/ehm581
22. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A, Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011 32 1730 1735. doi: 10.1093/eurheartj/ehr004
23. Kopel E, Klempfner R, Goldenberg I, Influenza vaccine and survival in acute heart failure. Eur J Heart Fail 2014 16 264 270. doi: 10.1002/ejhf.14
24. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014 371 993 1004. doi: 10.1056/NEJMoa1409077
25. Kyriacou DN, Lewis RJ, Confounding by indication in clinical research. JAMA 2016 316 1818 1819. doi: 10.1001/jama.2016.16435
26. Tamura S, Tanimoto T, Kurata T, Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn J Infect Dis 2005 58 195 207
27. Vaccines against influenza WHO position paper: November 2012. Wkly Epidemiol Rec 2012 87 461 476
28. Yancy CW, Mariell J, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C, 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 2017 136 e137 e161. doi: 10.1161/CIR.0000000000000509
29. Flather MD Yusuf S, Køber L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moyé L, Braunwald E, Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients: ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000 355 1575 1581
30. McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW, Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med 2009 150 784 794
31. Corrales-Medina VF, Madjid M, Musher DM, Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010 10 83 92. doi: 10.1016/S1473-3099(09)70331-7
32. Fagnoul D, Pasquier P, Bodson L, Ortiz JA, Vincent JL, De Backer D, Myocardial dysfunction during H1N1 influenza infection. J Crit Care 2013 28 321 327. doi: 10.1016/j.jcrc.2013.01.010
33. Paddock CD, Liu L, Denison AM, Bartlett JH, Holman RC, Deleon-Carnes M, Emery SL, Drew CP, Shieh WJ, Uyeki TM, Zaki SR, Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 2012 205 895 905. doi: 10.1093/infdis/jir861